학술논문
LBA91 TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T+O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1332-S1332
Subject
Language
ISSN
0923-7534